What were the main drivers of Cardinal Health's revenue growth in fiscal year 2007?

Cardinal Health's revenue grew by 9% to $86.9 billion in fiscal year 2007. The primary driver was the Healthcare Supply Chain Services — Pharmaceutical segment, which represents about 86% of total segment revenue. This growth was fueled by increased volume from both bulk and non-bulk customers and by pharmaceutical price appreciation.

Why did Cardinal Health's operating earnings decrease significantly in fiscal year 2007?

Operating earnings decreased by 26% to $1.4 billion due to significant "special items" totaling $772 million. The major components of these special items were reserves for litigation settlements ($655 million) and in-process research and development expenses, largely related to the Viasys acquisition ($85 million).

What was the impact of the PTS Business divestiture on Cardinal Health's financial results?

The divestiture of the PTS Business resulted in an after-tax book gain of approximately $1.1 billion. This gain significantly boosted net earnings, which increased by 93% to $1.9 billion in fiscal year 2007. The net proceeds of approximately $3.1 billion were used to repurchase the company's common shares.

How did Cardinal Health manage its capital and return value to shareholders in fiscal year 2007?

Cardinal Health was active in returning capital to shareholders in fiscal year 2007. The company repurchased approximately $3.8 billion of its common shares and also increased its quarterly dividend payments. These activities supported the company's long-term goal of returning 50% of net cash from operating activities to shareholders.

CAH 10-K FY2007 Annual Report — Revenue, Net Income, EPS

01—Abstract

Summary

Summary of the 10-K/A filed May 8, 2008. Cited figures are marked; the original filing is the authoritative source.

Cardinal Health Inc. (CAH) reported strong revenue growth in fiscal year 2007, reaching $86.9 billion^a, a 9% increase from the prior year.

This growth was primarily driven by its Pharmaceutical Supply Chain Services segment, which accounted for approximately 86% of total segment revenue, and supported by increased volume from both bulk and non-bulk customers, as well as pharmaceutical price appreciation. However, the company experienced a significant decrease in operating earnings, down 26% to $1.4 billion^b, largely due to substantial "special items" totaling $772 million. These special items were predominantly driven by litigation settlement reserves ($655 million) and in-process research and development expenses related to acquisitions.

Despite the decline in operating earnings, net earnings saw a substantial increase of 93% to $1.9 billion^c, primarily due to a $1.1 billion after-tax gain from the divestiture of its PTS Business. The company also actively returned capital to shareholders through $3.8 billion in share repurchases and increased dividend payments.

02—Key points

Key Highlights

Revenue grew 9% to $86.9 billion in fiscal year 2007, driven by the Pharmaceutical Supply Chain Services segment.
Operating earnings declined 26% to $1.4 billion due to $772 million in "special items," primarily litigation settlement reserves.
Net earnings increased 93% to $1.9 billion, largely attributed to a $1.1 billion after-tax gain from the sale of the PTS Business.
The company repurchased approximately $3.8 billion of its common stock during fiscal year 2007.
Strategic acquisitions were made, including Viasys for approximately $1.5 billion, to enhance product offerings.
The company reorganized its reportable segments into five categories to better align operations with customer needs.
Despite increased customer discounts impacting gross margins, the company expects to mitigate these pressures through sales growth, cost controls, and synergies from acquisitions.

03—Questions

Frequently Asked Questions

What were the main drivers of Cardinal Health's revenue growth in fiscal year 2007?
Cardinal Health's revenue grew by 9% to $86.9 billion in fiscal year 2007. The primary driver was the Healthcare Supply Chain Services — Pharmaceutical segment, which represents about 86% of total segment revenue. This growth was fueled by increased volume from both bulk and non-bulk customers and by pharmaceutical price appreciation.
Why did Cardinal Health's operating earnings decrease significantly in fiscal year 2007?
Operating earnings decreased by 26% to $1.4 billion due to significant "special items" totaling $772 million. The major components of these special items were reserves for litigation settlements ($655 million) and in-process research and development expenses, largely related to the Viasys acquisition ($85 million).
What was the impact of the PTS Business divestiture on Cardinal Health's financial results?
The divestiture of the PTS Business resulted in an after-tax book gain of approximately $1.1 billion. This gain significantly boosted net earnings, which increased by 93% to $1.9 billion in fiscal year 2007. The net proceeds of approximately $3.1 billion were used to repurchase the company's common shares.
How did Cardinal Health manage its capital and return value to shareholders in fiscal year 2007?
Cardinal Health was active in returning capital to shareholders in fiscal year 2007. The company repurchased approximately $3.8 billion of its common shares and also increased its quarterly dividend payments. These activities supported the company's long-term goal of returning 50% of net cash from operating activities to shareholders.

04—Continue

← View all 10-K filings